Early Detection Research Network

CD248

Aliases:
This biomarker is also known as:
  • CD164 sialomucin-like 1,
  • CD248,
  • CD164L1,
  • TEM1,
  • Endosialin,
  • tumor endothelial marker 1,
  • CD248 antigen, endosialin,
  • endosialin,

Description…

CD248 is a 165-kD cell surface glycoprotein expressed in tumor endothelial cells but absent or barely detectable in normal endothelial cells. There is also evidence that CD248 is expressed in metastatic lesions of the liver and during angiogenesis of corpus luteum formation and wound healing, in vascular endothelial cells of malignant tumors but not in normal blood vessels, and in stromal fibroblasts.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Under Review
Type: Protein
HGNC Name: CD248

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.